Zobrazeno 1 - 8
of 8
pro vyhledávání: '"Hiroyuki Ginba"'
Autor:
Michio Sata, Tatsuya Ide, Hiroyuki Ginba, Takashi Kumada, Koichi Takaguchi, Namiki Izumi, Kazuhiro Matsuyama, Noritomo Shimada, Hidenori Toyoda
Publikováno v:
Intervirology. 57:289-296
Objective: Some patients with chronic hepatitis C virus (HCV) infection fail to achieve complete early virologic response (EVR) despite a marked decrease in HCV RNA at 4 weeks. We investigated the characteristics and final treatment outcomes of this
Autor:
Shinichiro Okamoto, Yasuhiko Sakakura, Yuko Kitagawa, Naoki Aikawa, Masaki Kitajima, Junzo Takeda, Shingo Hori, Naoki Hasegawa, Hiroyuki Ginba, Hideaki Obara, Mitsuru Murata, Yoshio Kobayashi, Yasuo Ikeda, Minoru Tanabe
Publikováno v:
Journal of Infection and Chemotherapy. 17:327-333
The rapid diagnosis of pathogens and prompt initiation of appropriate antibiotic therapy are critical factors to reduce the morbidity and mortality associated with sepsis. In this study, we evaluated a multiplex polymerase chain reaction (PCR-M) test
Autor:
Takeshi Mizuno, Chiharu Ueguchi, Heisaburo Shindo, Hiroyuki Ginba, Toshimasa Yamazaki, Etsuko Katoh, Ayumi Ohnuki
Publikováno v:
FEBS Letters. 455:63-69
The DNA binding domain of H-NS protein was studied with various N-terminal deletion mutant proteins and identified by gel retardation assay and heteronuclear 2D- and 3D-NMR spectroscopies. It was shown from gel retardation assay that DNA binding affi
Autor:
Tatsuya Ide, Koichi Takaguchi, Hiroyuki Ginba, Namiki Izumi, Michio Sata, Hidenori Toyoda, Kazuhiro Matsuyama, Takashi Kumada, Noritomo Shimada
Publikováno v:
BMC Infectious Diseases, Vol 12, Iss 1, p 324 (2012)
BMC Infectious Diseases
BMC Infectious Diseases
Background The importance of the reduction in hepatitis C virus (HCV) RNA levels 4 and 12 weeks after starting peginterferon (PEG-IFN) and ribavirin combination therapy has been reported to predict a sustained virologic response (SVR) in patients inf
Autor:
Hidenori Toyoda, Koichi Takaguchi, Takashi Kumada, Kazuhiro Matsuyama, Michio Sata, Noritomo Shimada, Tatsuya Ide, Hiroyuki Ginba, Namiki Izumi
Publikováno v:
Journal of medical virology. 85(1)
Both baseline predictive factors and viral response at week 4 of therapy are reported to have high predictive ability for sustained virologic response to peginterferon and ribavirin combination therapy in patients with hepatitis C virus (HCV) genotyp
Autor:
C. Nelson Hayes, Kazuaki Chayama, Michio Imamura, Daiki Miki, Masataka Tsuge, Kazuhiro Matsuyama, Eisuke Murakami, Shoichi Takahashi, Hidenori Ochi, Hiroyuki Ginba, Hiromi Abe, Hiroiku Kawakami, Nobuhiko Hiraga
Publikováno v:
Journal of gastroenterology. 48(10)
Treatment for chronic hepatitis B has improved drastically with the use of nucleot(s)ide analogues (NAs). However, NA therapy typically fails to eliminate Hepatitis B virus (HBV) completely, and it is difficult to discontinue these therapies. We prev
Autor:
Hamad Ibrahim Al-Ashgar, Agnes Tóth, Guojian Li, John SantaLucia, Vladimira Ďurmanová, Jung Il Lee, Xueyan Wang, Hyung Joon Yim, Tim J. Harrison, Jean Zukurov, Ju Hyun Kim, Wagner Alkmim, Jin Woo Lee, Ali Agacfidan, Soon Koo Baik, Ahmed Helmy, Namiki Izumi, Ricardo S. Diaz, Rolf Kaiser, Patricia Munerato, Yun Soo Kim, Balazs Ásványi, Noritomo Shimada, Moon Young Kim, Luiz Mário Janini, Esam I. Azhar, Zhongliao Fang, Moujahed Kao, Ayper Somer, Yeon Seok Seo, Juliana T. Maricato, Ervin Pitlik, Satz Mengensatzproduktion, Tariq A. Madani, Koichi Takaguchi, Thomas G. Ksiazek, Shujia Liang, El-Tayeb M.E. Abuelzein, Michio Sata, Sun Pyo Hong, Myung Seok Lee, Ahmed Farouk Hasanain, Nadine Lübke, Ali Soliman Ali, Fuxiong Liang, Baki Akgül, Badr E. Masri, Shazi Shakil, Soon Ho Um, Sang Jun Suh, Hee Bok Chae, Laszlo Stipkovits, Mohammed Noreen Al-Ahdal, Wei Liu, Jinye Yang, Hiroyuki Ginba, Chang Don Lee, Sayed Sartaj Sohrab, M. Cecília Sucupira, Kazuhiro Matsuyama, Hidenori Toyoda, Sang Hoon Park, Jens Verheyen, Suha A. Farraj, Chang Wook Kim, Julius Rajčáni, Xinghua Wu, Cristiano Teodoro Russo, Druckerei Stückle, Zhenzhu Tang, Liushuai Feng, Noora A. Al-Kaiedi, Zhiyong Shen, Choong Kee Park, Özlem Yoldaş, Tatsuya Ide, Ahmed Ali Al-Qahtani, Susan Szathmary, Takashi Kumada, Hyun Jung Lee, Hadeel Al Mana, Kalman Szenthe, Hussein M.S. Al-Bar, Selda Hançerli
Publikováno v:
Intervirology. 56:X-X
Autor:
Naoki Hasegawa, Osamu Tasaki, Seishi Asari, Shinichiro Okamoto, Hisashi Sugimoto, Hiroyuki Ginba, Masao Tomonaga, Kazuyuki Sugahara, Yuko Kitagawa, Shigeru Kohno, Akitoshi Ishizaka, Shingo Hori, Masafumi Seki, Katsunori Yanagihara, Asako Matsushima, Shimeru Kamihira, Kunihiro Tsukasaki, Yasuo Ikeda, Yoshinobu Sumiyama, Hideaki Obara, Takeshi Shimazu, Naoki Aikawa, Junzo Takeda, Masaki Kitajima, Mitsuru Murata, Yoshio Kobayashi
Publikováno v:
Critical Care
Introduction: Sepsis is a serious medical condition that requires rapidly administered, appropriate antibiotic treatment. Conventional methods take three or more days for final pathogen identification and antimicrobial susceptibility testing. We orga